Ginsenoside CK inhibits migration and invasion of human osteosarcoma cells and TGF-β-induced A549 cells via PI3K/mTOR/p70S6K1 and SIRT [37,38]. The gene discussed is RPS6KB1; the disease is osteosarcoma.